<VariationArchive VariationID="1457456" VariationName="NC_000002.11:g.(?_31751266)_(31751352_?)del" VariationType="Deletion" Accession="VCV001457456" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1393397" VariationID="1457456">
      <GeneList>
        <Gene Symbol="SRD5A2" FullName="steroid 5 alpha-reductase 2" GeneID="6716" HGNC_ID="HGNC:11285" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="31522480" stop="31663009" display_start="31522480" display_stop="31663009" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="31749655" stop="31806039" display_start="31749655" display_stop="31806039" Strand="-" />
          </Location>
          <OMIM>607306</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_31751266)_(31751352_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="31751266" innerStop="31751352" display_start="31751266" display_stop="31751352" variantLength="87" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_31751266)_(31751352_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_31751266)_(31751352_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_31751266)_(31751352_?)del AND 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" Accession="RCV001953764" Version="4">
        <ClassifiedConditionList TraitSetID="853">
          <ClassifiedCondition DB="MedGen" ID="C0268297">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1522235</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20493473</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26446026</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5821" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pseudovaginal perineoscrotal hypospadias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency</ElementValue>
                <XRef ID="MONDO:0009923" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Male pseudohermaphroditism due to 5-alpha-reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial incomplete male pseudohermaphroditism, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency</ElementValue>
                <XRef ID="57514000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPSH</ElementValue>
                <XRef Type="MIM" ID="264600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5680" />
                <XRef ID="5680" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508993" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="753" DB="Orphanet" />
              <XRef ID="C0268297" DB="MedGen" />
              <XRef ID="MONDO:0009923" DB="MONDO" />
              <XRef Type="MIM" ID="264600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4263224" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000348.3_2_Deletion (exon 5)|MedGen:C0268297" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002240769" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1522235</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20493473</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26446026</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the SRD5A2 protein in which other variant(s) (p.Arg246Gln) have been determined to be pathogenic (PMID: 1522235, 20493473, 26446026). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with SRD5A2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 5 of the SRD5A2 gene. The 5' boundary is likely confined to intron 4. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRD5A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_31751266)_(31751352_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268297" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4263224" TraitType="Disease" MappingType="XRef" MappingValue="C0268297" MappingRef="MedGen">
        <MedGen CUI="C0268297" Name="3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

